Clinical trial
Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes…
NCT00481975 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00481975 |
|---|---|
| Title | Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese Patients |
| Official title | A Randomized, Double-Bind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study to Assess Efficacy and Safety of Rimonabant 20 mg Versus Placebo on Weight Loss and Frequency of Binge Episodes in Obese Patients With Food Craving |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity, Eating Disorders |
| Intervention type | Drug |
| Interventions | rimonabant (SR141716) |
| Enrollment | 289 |
| Start date | Aug 1, 2004 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Jun 4, 2007 |
| Last update posted | Apr 7, 2009 |
| Countries | Finland, France, Netherlands, Portugal, Sweden, Switzerland, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: